Conversely, M2-like TAMs are driven by IL-4, IL-13, and IL-10, and promote tumor progression by releasing immunosuppressive factors (PGE2, TGF-β, IL-10), and pro-angiogenic mediators (FGF, PDGF, VEGF) (14). This evidence concerns the gene TGFB1 and neoplasm.